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Sthe boundary was ﬁnally crossed again at patient 51, and the procedure remained
under control since.
Conclusions: The failure of a TAVI procedure may be due to several factors, many of
which are not directly related to the operative technique itself. By allowing the early
identiﬁcation of negative trends, the CUSUM charts may prompt internal audits aimed
to the identiﬁcation of the causes of failure, helping to take the procedure back into
control.
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Background: Aortic stenosis (AS) increases left ventricular (LV) ﬁlling pressure.
Total isovolumic time (t-IVT: the time when the LV is neither ejecting nor ﬁlling: i.e.
'wasted' time) is a marker of global left ventricular (LV) dyssynchrony. T-IVT is long
when LV dyssynchrony is present and is short when LV ﬁlling pressure is raised.
Relief of AS reduces LV ﬁlling pressures and may unmask LV dyssynchrony. We
hypothesised that prolongation of t-IVT after trans-aortic valve implantation (TAVI)
could provide a simple echocardiographic marker for the presence of LV
dyssynchrony.
Methods: 79 consecutive patients (aged 837 years) with severe AS but no ﬂow-
limiting coronary artery disease were studied one week before and 6 weeks after
TAVI. Using transthoracic echo, total LV ejection (t-ET) and ﬁlling times (t-FT) were
measured and expressed in seconds/min. T-IVT was then derived as [60 minus (t-ET
plus t-FT)]. Incoordination was measured as amplitude of continued inward motion of
the lateral wall after aortic valve closure. Patients were compared to 32 normal
subjects (aged 665 years).
Results: In controls, t-ET was 203s/min, t-FT was 293s/min, t-IVT was thus
112s/min, and there was no incoordination. In patients pre-TAVI, t-ET was pro-
longed compared to controls (243s/min, p<0.01), t-FT was not different (293s/
min, p¼NS), and t-IVT ('wasted time') was signiﬁcantly shorter (72s/min, p<001).
Incoordination was present (31mm). After TAVI, mean aortic pressure drop fell
(from 4915mmHg to 82mmHg, p<0.001) and both t-ET and t-FT shortened (t-ET
to 213s/min, p<0.01; t-FT to 263s/min, p<0.05), so that t-IVT ('wasted time')
increased (to 133s/min, p<0.001 compared to pre-TAVI). At the same time, inco-
ordination increased (to 52mm, p<0.01).
Conclusions: Patients with signiﬁcant AS have longer ejection time compared to
controls. Relief of AS after TAVI is associated with signiﬁcant shortening of ejection
time. The appearance of early diastolic incoordination, presumably due to a reduction
in LV ﬁlling pressure, concurrently shortens the available time for LV ﬁlling. The
overall result, signiﬁcant prolongation of total isovolumic time, may therefore be
a marker of LV dysynchrony after TAVI.
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Background: SAVR is the standard procedure for symptomatic aortic stenosis while
TAVI is the method of choice in patients at high risk. It is gaining increasing
importance in intermediate risk patients but to date there are limited data to assess
beneﬁts and risks.
Methods: Analyses were based on the TAVIK registry of patients undergoing TAVI
or SAVR between 2007 and 2012. For this analysis only patients with a logistic
EuroSCORE (ES)15 were considered. Both groups were compared using Propensity
Score Matching.
Results: As of April 2012 a total of 1,825 patients (1,003 TAVI/822 SVAR) were
included into TAVIK. 1,141 had a ES15 (419 TAVI/722 SAVR). The mean ES was
10.12.8 in the TAVI and 5.73.2 in the SAVR (p<0.0001). 3-yaers Survival was
higher in SVAR (p¼0.0023). 432 patients were considered for the matched-pairs
analysis based on the propensity score. The mean ES was 8.72.7 and 8.82.8
respectively (p¼0.52). Major vascular complications (10.6% vs. 0.0%; p<0.0001),JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrnew pacemaker implantation (13.9% vs. 4.6%; p<0.001) and moderate aortic insuf-
ﬁciency (3.2% vs. 0.5%; p¼0.03) were more in TAVI. Major (20.8% vs. 4.2%;
p<0.0001) and life-threatening (14.5% vs. 2.3%; p<0.0001) bleeding complications
were more in SVAR. Survival probability over three years in the propensity matched
cohort comparable between both groups (Log-Rank test p¼0.2196).
Conclusions: Based on one of the largest single center "real world" datasets (TAVIK),
we were not able to show a differential prognosis for intermediate risk patients
undergoing transcatheter or surgical aortic valve replacement after adjusting for
baseline risk.TCT-740
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Background: The impact of left geometric adaptive patterns in patients with aortic
stenosis undergoing transcatheter aortic valve replacement (TAVR) has not been
established.
Methods: The left ventricular mass (LVMi) and the relative wall thickness (RWT)
were indexed to the body surface area and gender. A normal LVMi was considered
95 g/m2 in women and 115 g/m2 in men. Normal LVg was considered if LVMI
was normal and RWT was 0.42. Concentric hypertrophy was deﬁned as LVMI
above the threshold together with RWT >0.42, but if RWT was below this cut-off,
eccentric hypertrophy was present. Concentric remodeling was deﬁned when the
LVMi was normal but RWT >0.42. Valve Academic Research Consortium (VARC)
criteria were used for procedural success. We compared the mortality rates at 1 year by
the Kaplan-Meier method.
Results: A total of 357 consecutive patients underwent TAVR. Normal geometry was
present in 10% of patients while concentric remodeling, concentric hypertrophy and
eccentric hypertrophy were present in 40%, 41% and 9%, respectively. The age,
baseline clinical characteristics, STS score and the VARC success rates were similar
among the different types of left geometry. The 1-year estimated mortality according
to ventricular geometry is shown in the Figure. (Log-Rank p <0.01)
Conclusions: The post-procedural left ventricular geometry adaptive pattern in
patients undergoing TAVR is associated with 1-year mortality. The concentric
remodeling represents the higher risk subgroup. Left ventricular geometry should be
followed in all patients post TAVR.acts/POSTER/Aortic Valve Disease and Treatment B225








Comparison of long-term clinical outcome between patients with chronic versus
acute type B aortic dissection treated by implantation of a stent graft:
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Background: Background: Stent grafting for treatment of type B aortic dissection has
been extensively used. However, the difference in the long-term clinical outcome
between patients with chronic versus acute type B aortic dissection remains unknown.
This study aimed to analyze the difference in long-term clinical outcome after
endovascular repair for patients with chronic ($2 weeks) versus acute (<2 weeks) type
B aortic dissection.
Methods: Between May 2000 and June 2011, a total of 174 patients with type B aortic
dissection (56 chronic, 118 acute) treated by endovascular repair were studied
prospectively. Follow-up three-dimensional computed tomography scanning and
aortoangiography were scheduled at 3–6 months after the index procedure. Propensity
score matching was used to compare the difference in the endpoint between the two
groups.
Results: The procedure-related event rate was 18.6% in the acute group and 5.4% in
the chronic group (P ¼ 0.021), but this difference became nonsigniﬁcant after
propensity score matching. At the end of follow-up (mean 2.49 years), overall and
aorta-related mortality was 11.0% and 7.6%, respectively, in the acute group, and was
not signiﬁcantly different from that in the chronic group (3.6% and 3.6%, P ¼ 0.148
and P ¼ 0.506, respectively). Both false and true lumina showed signiﬁcant remod-
eling over time, with .93% complete false-lumen thrombosis. Untreated tear and type I
endoleak were predictors of clinical events during follow-up.
Conclusions: Comparable long-term clinical results were achieved in patients with
chronic or acute type B aortic dissection after implantation of a stent graft.
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Background: Transcatheter aortic valve replacement (TAVR) via the transfemoral
(TF) approach is currently performed by both open surgical and percutaneous access.
Vascular complications are associated with morbidity and mortality, but few studies
have directly compared access approach.
Methods: Data was collected on all patients undergoing TF TAVR with Sapien or
Sapien XT aortic bioprostheses (Edwards Inc., Irvine, CA) between November 2007
and April 2013 at our institution. Valve Academic Research Consortium deﬁnitions
were utilized.
Results: TF TAVR was performed in 331 patients via an open surgical (n¼120) or
percutaneous (n¼211) approach. Both groups were similar in age, however the open
group had a greater incidence of cardiovascular comorbidities. The average sheath
outer diameter (OD) was slightly larger in the open group as compared to the
percutaneous group (8.6  0.4 vs. 8.4  0.6 mm, p<0.001). There were fewer major
vascular complications in the percutaneous as compared to the open group (11% vs.
20%, p¼0.03), and a trend toward fewer overall vascular complications (17% vs.
26%, p¼0.06). More patients with vascular complications in the percutaneous cohort
had minimal artery diameter (MAD) less than sheath OD (74% versus 55%, p¼0.03).
The percutaneous group had decreased length of stay (LOS) compared to the open
group (7.5  4.7 vs. 9.9  9.9 days, p¼0.003). There was no difference in in-hospital
mortality between the open and percutaneous groups (2.5 % vs. 1 %, p¼0.36). The use
of second generation TAVR sheaths and valves via a percutaneous approach was
associated with an even greater reduction in vascular complications (8% vs. 25%,B226 JACC Vol 62/18/Suppl B j October 27–Novemberp¼0.01) and LOS (7.0  4.8 versus 10.1  10.0 days, p¼0.04) as compared to the
open group with ﬁrst generation devices. Despite an increase in the difference between
sheath OD and MAD (-0.21 vs. 0.27 mm, p¼0.02) in the ﬁrst and second half of our
percutaneous access experience, the rates of vascular complications did not change
over this time.
Conclusions: TF TAVR via a percutaneous approach is associated with less vascular
morbidity and lower LOS as compared to an open surgical approach. These beneﬁts
are even greater with second-generation (Sapien XT) devices.
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Background: Valve academic research consortium (VARC) guidelines were devised
in an effort not only to standardize clinical endpoint deﬁnitions but also to select
endpoints that best reﬂect the safety and efﬁcacy of transcatheter aortic valve
replacement (TAVR). These guidelines are evolving in an expert led manner. We
sought to compare the predictive value for survival of major vascular complications
(VC) by VARC-1 and 2 deﬁnitions.
Methods: A large single center series of patients undergoing TAVR by multiple
approaches were studied. We deﬁned VC according to VARC-1 and VARC-2 deﬁ-
nition, and compared the mortality one year after the procedure. Data was analyzed
using Kaplan-Meier (KM) and Cox regression multivariable models that included all
variables related to 1-year mortality to a signiﬁcance level0.1.
Results: Data was analyzed for 388 patients. KM curves showed a numerically lower
survival rate at 1-year by major VC with both deﬁnitions, but only VARC-2 had
statistical signiﬁcance; 79.2% vs. 60.7% with VARC-2 (p ¼0.015), and 78.8% vs.
70.5% with VARC-1 (p ¼ 0.211). Cox regression multivariable model showed VC by
VARC-2 deﬁnition to be an independent predictor of 1-year mortality (p ¼ 0.004), but
not when VC was substituted by the VARC-1 deﬁnition (p¼0.08).
Conclusions: The VARC-2 deﬁnition for vascular complications offers better strati-
ﬁcation of survival than the VARC-1 deﬁnition, supporting its widespread use.
Reasons for this important difference will be discussed.TCT-744
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Background: Although prior studies describe the ﬂuoroscopic operator-independent
motion of the balloon-expandable valve, no studies have described the trans-
esophageal echocardiogram (TEE) appearance of valve deployment.
Methods: Intraoperative TEE from 100 consecutive* patients presenting for TAVR
were retrospectively analyzed. Patients with unreliable pacemaker capture or obvious
operator-induced device motion during deployment were excluded (n¼16). Device
position was deﬁned as the percent of total device height below the virtual annulus
(hinge points of aortic valve cusps). Device position was measured pre-deployment
(during rapid pacing) and post-deployment. Device cranial movement during
deployment was deﬁned as the difference between the pre-deployment and post-
deployment position (in mm) of the valve midpoint.1, 2013 j TCT Abstracts/POSTER/Aortic Valve Disease and Treatment
